Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.

Suppr

超能文献

作者信息

Bellet R E, Engstrom P F, Catalano R B, Creech R H, Mastrangelo M J

出版信息

Cancer Treat Rep. 1976 Sep;60(9):1395-7.

PMID:1016973

Abstract

摘要

相似文献

Phase II study of ICRF-159 in patients with metastatic colorectal carcinoma previously exposed to systemic chemotherapy.

Cancer Treat Rep. 1976 Sep;60(9):1395-7.

Phase III study of ICRF-159 versus 5-FU in the treatment of advanced metastatic colorectal carcinoma.ICRF-159与5-氟尿嘧啶治疗晚期转移性结直肠癌的III期研究。

Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1047-9.

Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma.

Cancer Chemother Rep. 1975 Jul-Aug;59(4):761-3.

Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.用三嗪酸酯、ICRF-159、5-氟尿嘧啶和甲基环己亚硝脲联合化疗晚期结直肠癌。

Cancer Treat Rep. 1980 Oct-Nov;64(10-11):1143-5.

Razoxane, metastasis and adjuvant chemotherapy.

Clin Exp Metastasis. 1987 Jan-Mar;5(1):1-2.

Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.

Cancer Treat Rep. 1985 May;69(5):543-5.

Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy.丙脒腙（ICRF-159）用于先前接受过全身化疗的头颈部鳞状细胞癌患者的II期试验。

Cancer Treat Rep. 1982 Mar;66(3):557-8.

Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.

Cancer Treat Rep. 1982 Dec;66(12):2093-4.

Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.

Cancer Chemother Pharmacol. 1982;8(3):293-9. doi: 10.1007/BF00254053.

Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.5-氟尿嘧啶治疗失败后，用三嗪酸盐和ICRF-159联合化疗晚期结直肠癌。

Oncology. 1980;37(5):314-5. doi: 10.1159/000225461.

引用本文的文献

Measurement of renal tumour and normal tissue perfusion using positron emission tomography in a phase II clinical trial of razoxane.在丙亚胺的II期临床试验中，使用正电子发射断层扫描测量肾肿瘤和正常组织灌注。

Br J Cancer. 2003 Jul 21;89(2):262-7. doi: 10.1038/sj.bjc.6601105.

An evaluation of the effectiveness and safety of razoxane when used as an adjunct to surgery in colo-rectal cancer. Report of a controlled randomised study of 603 patients.

Int J Colorectal Dis. 1993 Jul;8(2):106-10. doi: 10.1007/BF00299338.

Adjuvant oral razoxane (ICRF-159) in resectable colorectal cancer.

Cancer Chemother Pharmacol. 1982;8(3):293-9. doi: 10.1007/BF00254053.

Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.

Clin Exp Metastasis. 1984 Oct-Dec;2(4):321-31. doi: 10.1007/BF00135171.

Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors.每周一次静脉输注ICRF-187（NSC 169780）治疗实体瘤患者的I期临床试验及药代动力学研究

Invest New Drugs. 1987;5(2):187-98. doi: 10.1007/BF00203545.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验